Forest Laboratories Inc.

NYS : FRX
Pharmaceuticals
New York New York
2011 Revenue (US$ Millions)$4,420
2010 Revenue (US$ Millions)$4,193
Revenue Growth (%)5.41%
Net Income (US$ Millions)$1,047
Common Shares Outstanding (Millions)$286
Earnings Per Share (US$)$3.59
Earnings Per Share Growth (%)59.56%
Price To Earnings Ratio9.54
Total Equity (US$ Millions)$5,499
Profit Growth (%)53.4
Profit Margin (%)23.68%
Return On Equity (%)21.41%
Long Term Debt (US$ Millions)N/A
Debt To Equity Ratio (%)N/A
Market Capitalization (US$ Millions)$9,242
Total Assets (US$ Millions)$6,922
Return on Assets (%)16.82
Current Assets (US$ Millions)$5,260
Inventories (US$ Millions)$451
Current Liabilities (US$ Millions)$938
Cost of Goods Sold (US$ Millions)$964
Asset Turnover0.64
Inventory Turnover2.1